Search results for “Human insulin-like growth factor I” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 94 patents, we discovered top 22 key players by total patent application. Pierre Fabre Médicament SAS, Fujisawa Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd. are dominant in this area. They take 68.09% of the total patent filing.
France
Patent: 50
Osaka-fu, Japan
Patent: 10
Tokyo-to, Japan
Patent: 4
Tokyo-to, Japan
Patent: 3
Sweden
Patent: 3
South Korea
Patent: 2
New Jersey, United States
Patent: 2
Daiichi Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 2
South Korea
Patent: 2
Switzerland
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
No data, please try another search term
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
With the analysis among 6 patents, we discovered top 1 universities and scientific research institutions by total patent application.
Heilongjiang Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: